 | This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "COVID-19 vaccination in France" – news ·newspapers ·books ·scholar ·JSTOR(January 2023) (Learn how and when to remove this message) |
 | |
| Date | 27 December 2020 (2020-12-27) – present |
|---|---|
| Location | France |
| Cause | COVID-19 pandemic in France |
| Target | Full immunisation of people in France against COVID-19 |
| Participants | 53,895,155 people have received at least one vaccine dose 52,581,073 people have been fully vaccinated |
| Outcome | 80.3% of the French population have received at least one vaccine dose 78.3% of the French population have been fully vaccinated |
| Website | solidarites-sante |
COVID-19 vaccination in France started on 27 December 2020 after the approval ofPfizer–BioNTech COVID-19 vaccine by the European Union commission.
According to a June 2022 study published inThe Lancet, COVID-19 vaccination in France prevented an additional 631,000 deaths from December 8, 2020, to December 8, 2021.[1][2]
There are severalCOVID-19 vaccines at various stages of development around the world.
| Vaccine | Approval | Deployment |
|---|---|---|
| Pfizer–BioNTech |  21 December 2020 | 27 December 2020 |
| Moderna | 6 January 2021 | 12 January 2021 |
| Oxford–AstraZeneca | 29 January 2021 | 6 February 2021 |
| Janssen | 11 March 2021 | 23 April 2021 |
| Novavax | 20 December 2021 |  Not yet |
| Valneva | Pending | Not yet |
| Sanofi–GSK | Pending | Not yet |
| CureVac |  Request withdrawn | No |
| Vaccine | Type (technology) | Phase I | Phase II | Phase III |
|---|---|---|---|---|
| VLA2001 | Inactivated | Completed | Completed | In progress |
| CoVepiT | Subunit | In progress | Not yet | Not yet |
| TMV-083 | Viral vector |
The vaccination strategy put in place by the government has three principal objectives:[3]
The vaccine is planned to be distributed in five phases.
The first phase of vaccination concerns the highest-priority audiences. Since 27 December 2020, it initially concerned nursing home and ESMS residents and staff over the age of 50. Vaccination has been open to caregivers over 50 since 2 January 2021, then to firefighters and domestic caregivers over 50 since 5 January 2021.
This phase concerns people at high risk. From 18 January 2021, people aged 75 and over who do not reside in ESMS or nursing homes can be vaccinated. This phase will last until the end of February and concerns 5 million people. From the end of February, the vaccination will be open to people aged 65 to 74.
This phase concerns people who are more vulnerable than the general population. It will take place in the spring and include the following people.
Phases 4 and 5 will allow vaccination to be widely opened to those over 18.
Daily updates were provided bySanté Publique France.[5]
 | This graph was using thelegacy Graph extension, which is no longer supported. It needs to be converted to thenew Chart extension. |
| This graph was using thelegacy Graph extension, which is no longer supported. It needs to be converted to thenew Chart extension. |
The following table details the weekly number of authorized vaccines delivered to France since the start of the crisis.[6] Among the suppliers, AstraZeneca is by far the most late compared to its initial commitments. In the 1st quarter of 2021, AstraZeneca is expected to deliver 30 million doses to the European Union, while the initial forecast was 120 million.[7][8]
| This graph was using thelegacy Graph extension, which is no longer supported. It needs to be converted to thenew Chart extension. |
| This graph was using thelegacy Graph extension, which is no longer supported. It needs to be converted to thenew Chart extension. |